GENEVA, July 2 -- ASTRAZENECA UK LIMITED filed a patent application (IB2025/063101) for “COMBINATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND ANTI-TROP2 ANTIBODY-DRUG CONJUGATE”. With publication no. WO/2026/133218, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....